ERGENÇ, İlkay et al. RE: Risk of HBV Reactivation in HBsAg Negative and AntiHBc IgG Positive Patients Receiving Biologic Therapy. Turkish Journal of Gastroenterology, [S. l.], v. 34, n. 3, p. 310–310, 2023. DOI: 10.5152/tjg.2023.237002. Disponível em: https://www.turkjgastroenterol.org/index.php/tjg/article/view/4628. Acesso em: 3 mar. 2026.